Matthew Kappus

Caring for people w liver disease and their families. Cirrhosis, frailty, nutrition, prehab. Transplant hepatologist @Duke_GI. Husband, father, son, brother.

[Matthew Kappus @MatthewKappus]

@WendyHassonMD Strongly consider approaching your human resources point person. We can all learn from bad behavior. Repeat offenders are best documented this route.

[Matthew Kappus @MatthewKappus]

@Paul_Wischmeyer @drkeithsiau Cecal volvulus

[Matthew Kappus @MatthewKappus]

A myth that continues to be propagated…

[Jonathan G. Stine, MD MSc, FACP @JonathanStineMD]

I hear this mis-information all the time. DYK instead that #exercise training can lower portal pressures over time which may prevent MALOs???? 🏃‍♀️ @YucaSpice @MatthewKappus

[Jonathan G. Stine, MD MSc, FACP @JonathanStineMD]

It's here!

30 consensus, evidence-based statements about Physical Activity and #NAFLD from @ACSM roundtable out today in @MSSEonline!

https://t.co/61TzxHImCb

@fitaftercancer @DrMTLong @KathleenCoreyMD
@drbobsallis @AlinaAllenMD @conroylab @djrcuthbertson @CJAPugh

[Matthew Kappus @MatthewKappus]

@JasAWebb

[Matthew Kappus @MatthewKappus]

@alikhan28 This morning

[Matthew Kappus @MatthewKappus]

New #priorauth requirements for GI endoscopy procedures will hurt our patients. @UHC, don't implement the prior auth program on June 1 and cause more obstacles to care!

[Matthew Kappus @MatthewKappus]

A staggering 8️⃣0️⃣ % of physicians report that #priorauth can lead to treatment abandonment. We don’t need a program that will cause more delays to GI patient care! I’m writing @UHC to tell them to stop new prior auth requirements – have you? https://t.co/xy9xUDmXv0

[Matthew Kappus @MatthewKappus]

One of my favorite resources for patients and care givers to understand living with chronic liver disease...Check it out!

[Cirrhosis Care Alberta @CirrhosisCareAB]

Portal hypertension is a serious complication for patients with cirrhosis. It is important that patients and caregivers understand the cause & what to look for.

Refer your patients to the website to learn about PH, including definitions, images, & more!

https://t.co/2eNWBKfm2P

[Duke Infectious Diseases @DukeAdultID]

Today is Living Donor Day. #DonateLife #LivingDonorDay Won't you consider saving a life while you are still alive? Kidney and liver transplant candidates who are able to receive a living donor transplant can receive the best quality organ much sooner, often in less than a year.

[Matthew Kappus @MatthewKappus]

@ReenaHem @emoryimchiefs @EmoryDeptofMed Great work Dr. Hemrajani! Not surprised one bit!

[Jonathan G. Stine, MD MSc, FACP @JonathanStineMD]

@AlinaAllenMD @ACSMNews @AASLDtweets @EASLnews 🙏 incredible effort from to our all ⭐️ team @fitaftercancer @KathleenCoreyMD @DrMTLong @drbobsallis @Drfattyliver @HallsworthKate @EduardoVilarGo1 @YucaSpice @conroylab @djrcuthbertson @ingrid_hickman @MatthewKappus @shelley_keating @CJAPugh @NASH_and_coffee @Tracey_MD @VWSWong

[Hepatology Communications @HepCommJournal]

📑 @ACSMNews Proceedings Paper from the inaugural International Multidisciplinary Roundtable on #NAFLD and physical activity is out now!

⭐️Summarizes the latest evidence and identifies future research directions and knowledge gaps!!
#LiverTwitter
https://t.co/TrQ40BrkOZ

[David Leiman, MD, MSHP @David_LeimanMD]

Absolutely thrilled to present @WeillCornell & @WCM_GI 🗽
Thank you to Dr. Ara Lee for hosting and leading in quality and patient safety!
@RebeccaEBerger @CNewberryMD @FeliceSchnoll @christinemphmd

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

Characterization of social determinants of health of a liver transplant referral population
by @jackie_henson @AMuir_DukeGI @Julius__Wilder, @norinewchan et al of @Duke_GI_ & @DukeSurgery

https://t.co/9GWGockG2x

#livertwitter

[Matthew Kappus @MatthewKappus]

@yuvalpatelMD @ebtapper @rrosenblattmd @AutoImmuneLiver @HowardTLeeMD Reports of using thymoglobulin in literature as well. The steroid dose is high and taper has to be slow and can take some time before even beginning to taper. Once they show stable improvement, gradual taper and the amount depends on how much improvement there has been and SE

[Matthew Kappus @MatthewKappus]

@yuvalpatelMD @ebtapper @rrosenblattmd @AutoImmuneLiver @HowardTLeeMD I have used 1mg/kg solumedrol q8 and cellcept to start. In patients who are slow to respond, after ensuring no viral/other infectious process at play, I have increased the cellcept to 1500mg bid and slowly these patients have responded once the cellcept starts to take effect.

[Matthew Kappus @MatthewKappus]

@yuvalpatelMD @ebtapper @rrosenblattmd @AutoImmuneLiver @HowardTLeeMD In these severe cases, I have had to send the patient home on high dose prednisone (equivalent dosing to the 1mg/kid tid of solumedrol but typically in a bid dosage form) and tapered down from this slowly.

[Matthew Kappus @MatthewKappus]

Looking forward to welcoming my outstanding surgical partner and friend Lisa McElroy as she shares on her work evaluating social risk factors and transplant candidacy!
@Duke_GI_

[Duke GI @Duke_GI_]

Join us tomorrow @Duke_GI_ #GIGrandRounds for our featured #BlackHistoryMonth lecture series presenter, Lisa McElroy, MD, MS @DukeSurgery on social risk and #Transplant candidacy

@AmitPatelDukeMD @MatthewKappus @amcpherson1204

[Duke GI @Duke_GI_]

Join @duke_gi_ tomorrow for the 2nd week of our #BHM #GIGrandRounds series.
We're honored that special guest @DrFolaMay @uclahealth @deptvetaffairs will present "Colorectal Screening in Underserved Communities: Challenges and Solutions"
@AmitPatelDukeMD @MatthewKappus